What does laboratory peptide documentation require when you read HPLC results on a peptide COA?
A peptide certificate of analysis is a condensed laboratory peptide documentation pack, not a promotional summary. The HPLC results block is typically organised as a sample-information header, a method-identification line, a chromatogram, a peak table, and a specification-versus-result summary that includes chromatographic purity plus related-substances rows. Researchers in Australia should read those layers in that order. Opening at the purity percentage and working backwards is how mismatched lots and reused chromatograms escape notice.
The sample-information header should name the material, the manufacturer or internal laboratory lot, the sample identifier used by the chromatography data system, the analyst or electronic-signature identity, and the acquisition date-time. If any token disagrees with the COA letterhead lot number, the HPLC result is not yet evidence about the vial in hand. Structured reading of experimental material insists that a reported number is uninterpretable until the sample that produced it is identified, as discussed in Suggestions on how to read experimental material in information science. That principle is the first check on a peptide COA.
The method-identification line should carry a method ID, a revision or effective date, column chemistry and dimensions, detection wavelength or diode-array channel, a summary of the gradient or isocratic programme, and the sample-preparation description, including weighing, diluent, nominal concentration and chromatographic load. These fields exist so that a second laboratory can recognise whether two chromatograms are comparable.
Only after header and method concordance should the reviewer open the peak table and the impurity-summary rows. Chromatographic purity by area normalisation describes the main peak as a percentage of the summed integrated peak area after agreed exclusions such as the solvent front, a known counter-ion, or blank-derived artefacts. It is not an assay of peptide content and it is not net peptide content after water and counter-ion correction. Conflating those three quantities is the most common filing error in research procurement. File the COA, the chromatogram and the tracked-dispatch consignment note against one lot identifier so the pack would survive an internal audit without oral explanation.
What do specified, unspecified and total impurity rows on an HPLC COA actually report?
Specified-impurity rows name a related substance that the method is designed to resolve and quantify, usually as area per cent relative to the included peak-area sum. The name may be a chemical descriptor, such as a methionine sulphoxide analogue, a truncated sequence or an aspartimide species, or a laboratory code tied to a relative retention time window. The row should state the result, the unit and the acceptance limit. Reading the row means checking all three fields, not only a printed pass flag.
Unspecified-impurity rows collect peaks that exceed the reporting threshold, are not assigned to a named related substance, and are not excluded as solvent, blank or counter-ion. A complete COA reports the largest unspecified peak separately from the sum of unspecified peaks. If only a single any-unspecified figure appears, the reviewer cannot tell whether one large unknown or many small unknowns dominate. That distinction is a method-capability question: a single large unknown may indicate co-elution or a mis-integrated shoulder, whereas a spray of trace peaks near the reporting threshold may indicate integration-parameter sensitivity.
Total impurities is not always the arithmetic complement of chromatographic purity. Area-normalised purity is often calculated as main-peak area divided by the sum of all included peak areas, so purity plus included related substances equals 100 per cent by construction. Some laboratories calculate total impurities from a related-substances run that uses a different chromatographic load, a different gradient, or a different inhibit window around the main peak. In that design the purity run and the related-substances run are different experiments, and the two percentages should not be forced to add to 100 per cent. The COA should state which design was used.
Reporting threshold, sometimes called the ignore limit or reporting level, determines which peaks enter the unspecified and total rows. A threshold of 0.05 area per cent will populate more rows than a threshold of 0.10 area per cent. Comparing two lots or two suppliers without recording the threshold is not a comparison. Copy the threshold into the laboratory notebook beside the result. Guidance titled 13. How to read a journal article, published in the Medical Journal of Australia, emphasises reconstructing the decision rules that created a table rather than quoting the table in isolation. None of these rows is an efficacy statement. They characterise chromatographic composition of a research material under a stated method. Research use only.
How do HPLC chromatogram peak labels concord with the impurity-summary table?
The chromatogram is the primary record; the impurity-summary table is a derived summary. Concordance means that every peak contributing to a specified, unspecified or total-impurity row can be found on the chromatogram and in the peak table, with consistent retention time, relative retention time and area per cent. Australian reviewers should treat a COA that prints a purity number without a peak table as incomplete laboratory peptide documentation.
Peak labels on the plot should match peak names or codes in the table. If the plot says RRT 0.86 and the table says Impurity B, the COA must supply the mapping. If the plot is a raster image without labels, the reviewer can only estimate retention times from the axis, which is a weak audit position. Vector chromatograms with integration tick marks at peak start, apex and peak stop allow a second person to see whether a shoulder was dropped, skimmed or fully integrated. That visual check is part of how to read HPLC results, not an optional extra.
Relative retention time is the retention time of the peak divided by the retention time of the main peak in the same chromatogram. Because it is a ratio, modest absolute shifts from column ageing or mobile-phase preparation often leave RRT windows intact. Absolute retention time still matters for identity-supporting documentation: the main peak should fall inside the method identity window. If it does not, impurity RRTs calculated from it are not comparable to the method named-impurity catalogue.
Area-per-cent concordance is a numerical check. Sum the included peak areas from the table and confirm that reported chromatographic purity equals the main-peak area divided by that sum after the stated exclusions. If solvent or counter-ion peaks appear in the table but are excluded from the purity calculation, the exclusion must be footnoted. A mismatch larger than ordinary rounding, typically 0.1 area per cent on a one-decimal report, means the summary rows were not generated from the printed table. Finding information in Australian documentation systems depends on knowing which object is the source of truth, a point made in Documentation about Atlas of Living Australia tools: how to find information. For a peptide COA, the source of truth is the peak table plus the integration-event list, not the headline percentage.
Which lot-traceability and method-revision fields must match the HPLC results block?
Lot traceability is the reason laboratory peptide documentation exists. The HPLC results block must repeat the same lot token that appears on the vial label, the COA letterhead, the chromatogram sample name and the dispatch record. In Australian research procurement that chain distinguishes a documented research lot from an untraceable aliquot. Search interest in peptide lot traceability is a documentation problem, not a biological question.
Method revision is the second token. Related-substances limits, reporting thresholds and even which peaks are named can change when a method is revised. A result of 0.32 area per cent unspecified is interpretable only against the revision that defined the threshold and the RRT windows. The COA should print method ID and revision together. If a vendor reissues a COA with a new method revision but the same chromatogram file name, ask whether the chromatogram was reintegrated or merely relabelled.
Sample-name syntax in chromatography data systems is often the weakest link. Concatenated strings that bury material code, lot, vial position and replicate number are readable only if the vendor publishes the parsing rule. Laboratory peptide documentation should include that rule or should use delimited fields. Reviewers in Australia who archive chromatogram PDFs by filename should copy the lot token into the filename rather than relying on an opaque sequence number.
Tracked dispatch and local Australian stock do not replace analytical concordance, but they close the physical side of the chain: the lot that was documented is the lot that left the warehouse. This article does not discuss temperature-controlled transport. What is required to read HPLC results is a consignment identifier that points back to the same lot as the COA. For multi-vial research orders the pack should also state whether every vial shares one lot and therefore one chromatogram, or whether a cross-reference table from vial identifier to lot to COA is required.
A practical checklist: vial lot equals COA lot equals chromatogram sample name; method ID and revision on the chromatogram footer equal those on the COA; acquisition date is earlier than the COA approval date; column identity is consistent with the method; impurity rows can be recalculated from the peak table. Failing any item means the HPLC results are not yet attached to the material. How numerical results are read when they are adapted into a later quality system is a documentation skill, which is the question posed in HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE?
How should integration footnotes and dropped-peak flags be read on peptide COAs?
Integration events decide the impurity rows. Baseline placement, whether drop-line, valley-to-valley or tangential skim, together with peak-start and peak-stop times, minimum area or height, and inhibit windows around the solvent front, all change area per cent. Peptide COA documentation that omits these events cannot be independently reconstructed. How to read HPLC results therefore includes reading the footnotes beneath the peak table.
Common flags include peak not reported because it is below the reporting threshold, peak excluded as solvent, peak excluded because it corresponds to a blank, shoulder skimmed, and manual baseline. Each flag should be attributable to a rule in the method, not to an undocumented analyst preference. If a manual baseline was used, the COA should say so. Electronic audit trails in the chromatography data system are the underlying record; the COA is the summary. Australian laboratories that may later run orthogonal mass-spectrometric identity checks need to know whether they are reproducing a method or reproducing a one-off integration.
Dropped-peak flags matter most near the main peak. A close-eluting related substance absorbed into the main-peak baseline will inflate chromatographic purity and deflate specified or unspecified rows. Integration tick marks on an expanded main-peak region are the printed evidence of that decision. Full-scale plots that clip the main peak in order to display trace impurities are useful for related-substances viewing, but they are the wrong plot for judging main-peak integration.
Rounding and significant figures belong in the same reading step. Area per cent reported to one decimal place cannot support a limit expressed at 0.05 per cent unless the COA states how rounding is applied. Totals summed from rounded rows may differ from a total calculated from raw areas. The COA should state which total is reported. Read specification and result columns as a pair: a result without a limit is a characterisation value, not a release decision, and a pass flag without the numeric result is not laboratory peptide documentation of HPLC results. Keep the numeric result, the unit, the limit, the method revision and the lot token together in the research file. Formatted PDFs should not hide the underlying table, a caution that sits inside broader discussion of how published documents are presented to readers in Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read. Orthogonal electrospray mass spectrometry, where supplied, should be filed beside the HPLC block rather than treated as a substitute for area-per-cent rows. Research use only; this reading method does not authorise human use.
Apply this checklist to documented stock
You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.
Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.
Frequently asked questions
What counts as laboratory peptide documentation for an HPLC COA?
It is the retrievable pack that ties a vial lot to a method revision, a chromatogram, a peak table and the specified, unspecified and total impurity rows. In Australia the pack should also carry a tracked-dispatch consignment identifier matching the same lot. The pack characterises research material under a stated HPLC method and is not a medical record.
How do I read HPLC results if the COA shows only a purity percentage?
Treat the document as incomplete laboratory peptide documentation. Chromatographic purity by area normalisation cannot be reconstructed without the peak table, exclusion rules and reporting threshold. Request the labelled chromatogram with integration ticks and the impurity-summary rows before cataloguing the lot for research use.
What is the difference between unspecified impurities and total impurities on a peptide COA?
Unspecified impurities are peaks above the reporting threshold that are not named related substances and are not excluded as solvent, blank or counter-ion. Total impurities is the method-defined sum of included related substances and may come from the purity run or from a separate related-substances run. The COA must state which design was used.
Do HPLC impurity rows replace mass-spectrometric identity documentation?
No. HPLC area-per-cent rows describe chromatographic composition. Electrospray mass spectrometry reports observed mass relative to the theoretical monoisotopic mass. File both records side by side. Neither record is an efficacy statement; both are identity and purity documentation for laboratory research only.
Which identifiers should an Australian research buyer match before accepting HPLC results?
Match vial lot, COA letterhead lot, chromatogram sample name, method ID and revision, and the dispatch consignment identifier. If any token fails, the HPLC results are not yet attached to the material. Local Australian stock turns that match into a shelf check.
References
- DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
- DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
- DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
- DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
- DOI:10.1177/1329878x0210300127 — Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read — Media International Australia — 2002
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
